PYRIMIDINE-BASED COMPOUNDS FOR THE TREATMENT OF CANCER
申请人:G1 Therapeutics, Inc.
公开号:US20190119294A1
公开(公告)日:2019-04-25
This invention is in the area of pyrimidine-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.